Considering the numerous failures of Aβ-directed therapies and the stronger correlation of tau pathology with cognitive impairment and AD severity [33], a competing tau hypothesis has emerged, proposing tau pathology rather than Aβ as the primary trigger of the neuropathological events found in AD. The gene discussed is MAPT; the disease is Cognitive impairment.